Pulse Biosciences, Inc.
PLSE
$16.56
-$0.4899-2.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 106.35M | 119.28M | 118.04M | 79.03M | 26.20M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 51.00K | 30.00K | -- | -- | -- |
| Prepaid Expenses | 1.76M | 1.60M | 1.41M | 1.38M | 1.04M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 108.16M | 120.91M | 119.45M | 80.41M | 27.24M |
|
|
|||||
| Total Current Assets | 108.16M | 120.91M | 119.45M | 80.41M | 27.24M |
| Net Property, Plant & Equipment | 7.72M | 7.95M | 8.32M | 7.81M | 8.13M |
| Long-term Investments | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M |
| Goodwill | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M |
| Total Other Intangibles | 907.00K | 1.05M | 1.22M | 1.39M | 1.55M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 677.00K | 678.00K | 677.00K | 646.00K | 714.00K |
| Total Assets | 120.25M | 133.38M | 132.46M | 93.05M | 40.43M |
|
|
|||||
| Total Accounts Payable | 2.74M | 2.37M | 1.67M | 1.73M | 1.64M |
| Total Accrued Expenses | 4.78M | 3.98M | 5.83M | 3.82M | 3.18M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.46M | 1.41M | 1.36M | 1.19M | 1.15M |
| Total Finance Division Other Current Liabilities | -- | -- | 1.20M | -- | -- |
| Total Other Current Liabilities | -- | -- | 1.20M | -- | -- |
| Total Current Liabilities | 8.98M | 7.76M | 10.06M | 6.74M | 5.96M |
|
|
|||||
| Total Current Liabilities | 8.98M | 7.76M | 10.06M | 6.74M | 5.96M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.79M | 7.17M | 7.54M | 7.17M | 7.50M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.76M | 14.93M | 17.60M | 13.92M | 13.46M |
|
|
|||||
| Common Stock & APIC | 530.95M | 525.75M | 505.36M | 450.25M | 385.40M |
| Retained Earnings | -426.46M | -407.30M | -390.50M | -371.12M | -358.44M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 104.49M | 118.45M | 114.86M | 79.13M | 26.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 104.49M | 118.45M | 114.86M | 79.13M | 26.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 104.49M | 118.45M | 114.86M | 79.13M | 26.97M |
|
|
|||||